Related Experiment Video
Updated: Apr 18, 2026
13:22
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Published on: October 23, 2019
8.4K
Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy
1Department of Biochemistry, University of Zurich, CH-8057 Zurich, Switzerland;
Annual Review of Pharmacology and Toxicology
|January 7, 2015
Summary
Designed ankyrin repeat proteins (DARPins) offer robust alternatives to antibodies, enabling advanced applications in research and therapy. Their stability and unique properties are driving innovation in diagnostics, drug development, and clinical treatments.
Area of Science:
- Biotechnology
- Protein Engineering
- Molecular Biology
Background:
- Designed ankyrin repeat proteins (DARPins) exhibit high specificity and affinity, comparable to antibodies.
- DARPins possess superior robustness and stability, enabling diverse applications beyond traditional antibody uses.
Purpose of the Study:
- To review recent advancements in DARPin design and properties.
- To illustrate the diverse applications of DARPins in research and therapeutic development.
- To highlight the potential of DARPins in clinical settings.
Main Methods:
- Structure-based protein engineering for therapeutic DARPin development.
- Application of DARPins as intracellular sensors and crystallization chaperones.
- Development of DARPin-based conjugates and fusions for various applications.
Main Results:
- DARPins function as real-time intracellular protein conformation sensors and crystallization chaperones.
- Engineered DARPins selectively induce tumor apoptosis by disrupting receptor signaling.
- DARPins show promise in virus retargeting and have demonstrated safety and efficacy in macular degeneration clinical trials.
Conclusions:
- DARPin technology offers a stable, soluble, and aggregation-resistant platform for advanced molecular tools.
- The versatility of DARPins supports a wide range of applications, from basic research to clinical therapies.
- Ongoing clinical trials underscore the therapeutic potential and safety profile of DARPins.
Related Concept Videos
01:09Cytoskeletal Linker Proteins - Plakins
3.1K
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
3.1K
01:27Transducer Mechanism: Enzyme-Linked Receptors
5.1K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
5.1K